MedTrace Logo

Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis

NCT02952079 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2018-06-08

No results posted yet for this study

Summary

The goal of this study is to compare which treatment - BlephEx or MiBoFlo - will be a better option for patients suffering from dry eye secondary to Meibomian Gland dysfunction.

Conditions

  • Meibomian Gland Dysfunction
  • Dry Eye
  • Posterior Blepharitis

Interventions

DEVICE

Blephex

Lid margin exfoliation

DEVICE

MiboFlo

Lid warming treatment

Sponsors & Collaborators

  • University of the Incarnate Word

    lead OTHER

Principal Investigators

  • Srihari Narayanan, OD, PhD · University of the Incarnate Word

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02952079 on ClinicalTrials.gov